Welcome to our dedicated page for Argenx Se SEC filings (Ticker: ARGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading a biotech filing often feels like decoding an immunology textbook. argenx’s 10-K alone details antibody platforms, clinical burn rates, and regulatory hurdles that can redefine its valuation overnight. If you have ever asked, “How do I find argenx insider trading Form 4 transactions just before an FDA decision?” or “Which page in the quarterly 10-Q explains R&D spend on subcutaneous formulations?”—this page is built for you.
Stock Titan’s AI analyses every disclosure the moment it hits EDGAR. Whether it’s an argenx quarterly earnings report 10-Q filing, an unexpected 8-K material event explained, or argenx Form 4 insider transactions real-time, our system extracts the trial milestones, cash-runway updates, and executive stock moves that matter. Interactive summaries translate dense scientific language into concise insights, so understanding argenx SEC documents with AI becomes a two-minute task instead of an afternoon.
Use this hub to track:
- Annual report 10-K simplified—see how revenue from approved therapies balances multi-year R&D investments.
- Proxy statement executive compensation—compare CEO incentives to pivotal trial timelines.
- argenx earnings report filing analysis—spot quarter-over-quarter shifts in manufacturing costs.
- Executive stock transactions Form 4—monitor insider sentiment ahead of clinical readouts.
Updated in real time and explained simply, every argenx 8-K, 10-Q, 10-K, S-8, and Form 4 is here, ready for professionals who need facts—fast.
Artisan Partners and affiliated entities report beneficial ownership of 2,349,776 American Depositary Shares of Argenx, representing 3.8% of the 61,166,252 ADS outstanding. The filing shows no sole voting or dispositive power; instead the filers report shared voting power of 2,010,189 ADS and shared dispositive power of 2,349,776. The reporting persons are Artisan Partners Asset Management Inc., Artisan Partners Holdings LP, Artisan Investments GP LLC and Artisan Partners Limited Partnership, all organized in Delaware with a principal business address in Milwaukee, WI.
The statement is made on Schedule 13G and includes a joint filing agreement among the reporting persons, and it certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
argenx SE (ARGX) has filed a Form 6-K for June 2025. The filing’s sole purpose is to furnish a press release dated 20 June 2025, attached as Exhibit 99.1 and incorporated by reference into the company’s outstanding Form S-8 registration statements (File Nos. 333-225375, 333-258253 and 333-274721). No financial statements, earnings figures, or transactional details are included in the filing, and the text does not disclose the subject matter of the referenced press release. The document therefore serves an administrative function, ensuring the press release is part of the SEC record and automatically updates the company’s registration statements.
FAQ
What is the current stock price of Argenx Se (ARGX)?
What is the market cap of Argenx Se (ARGX)?
